Briggs Morrison
Impact in
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Oncology 6
- Cancer-related Molecular Pathways 4
-
- Monoclonal and Polyclonal Antibodies Research 3
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Barry J. Gertz (2 shared papers)Brendan McAdam (1 shared paper)Kenneth C. Lasseter (1 shared paper)Dean A. Kujubu (1 shared paper)Garret A. FitzGerald (1 shared paper)Hui Quan (1 shared paper)Francesca Catella-Lawson (1 shared paper)Shiv Kapoor (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Therapeutic Innovation & Regulatory Science (2 papers)Journal of Biological Chemistry (2 papers)International Journal of Cancer (2 papers)Nature Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Briggs Morrison
23 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 126
- Pharmacology 626
- Biochemistry 253
- Pharmacology 126
- Cardiology and Cardiovascular Medicine 197
- Immunology 182
Countries citing papers authored by Briggs Morrison
This map shows the geographic impact of Briggs Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Briggs Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Briggs Morrison more than expected).
Fields of papers citing papers by Briggs Morrison
This network shows the impact of papers produced by Briggs Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Briggs Morrison. The network helps show where Briggs Morrison may publish in the future.
Co-authors
The 25 scholars most cited alongside Briggs Morrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 478 | |
| 2 | 1996 | 142 | |
| 3 | Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group. | 1999 | 132 |
| 4 | 1995 | 131 | |
| 5 | A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer. | 2002 | 72 |
| 6 | 2004 | 67 | |
| 7 | 2011 | 60 | |
| 8 | 2002 | 56 | |
| 9 | 1999 | 45 | |
| 10 | 2000 | 44 | |
| 11 | 1953 | 42 | |
| 12 | 1992 | 39 | |
| 13 | 2018 | 30 | |
| 14 | 1989 | 28 | |
| 15 | 2012 | 15 | |
| 16 | 2013 | 14 | |
| 17 | 2012 | 13 | |
| 18 | 2012 | 9 | |
| 19 | 1999 | 8 | |
| 20 | 1994 | 5 |
About Briggs Morrison
Briggs Morrison is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology and Pharmacology, having authored 23 papers that have together received 1.4k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Cancer-related Molecular Pathways (4 papers), Immunotherapy and Immune Responses (3 papers), Meta-analysis and systematic reviews (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Biosimilars and Bioanalytical Methods (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Pharmacology (626 citations), Biochemistry (253 citations), Pharmacology (126 citations), Cardiology and Cardiovascular Medicine (197 citations) and Immunology (182 citations). Briggs Morrison has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Barry J. Gertz, Brendan McAdam, Kenneth C. Lasseter, Dean A. Kujubu, Garret A. FitzGerald, Hui Quan, Francesca Catella-Lawson, Shiv Kapoor, Lisa M. Antes and Philip Leder. Their work appears in journals such as Clinical Cancer Research, Therapeutic Innovation & Regulatory Science, Journal of Biological Chemistry, International Journal of Cancer and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.